+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Syphilis Immunoassay Diagnostic Market Research Report by Product (Analyzer and Kit & Reagent), by Technology (CLIA and ELISA), by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995105
  • Report
  • July 2021
  • Region: Global
  • 183 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Syphilis Immunoassay Diagnostic Market will Grow to USD 445.83 Million by 2026, at a CAGR of 8.32%

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter Inc
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • MORE
The Global Syphilis Immunoassay Diagnostic Market size was estimated at USD 275.95 Million in 2020 and expected to reach USD 297.99 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.32% to reach USD 445.83 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Syphilis Immunoassay Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Syphilis Immunoassay Diagnostic Market was studied across Analyzer and Kit & Reagent.
  • Based on Technology, the Syphilis Immunoassay Diagnostic Market was studied across CLIA and ELISA.
  • Based on End User, the Syphilis Immunoassay Diagnostic Market was studied across Blood Bank, Diagnostic Lab, and Hospital.
  • Based on Region, the Syphilis Immunoassay Diagnostic Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Syphilis Immunoassay Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Syphilis Immunoassay Diagnostic Market, including Abbott Laboratories, Beckman Coulter Inc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Fujirebio, Inc., Gold Standard Diagnostics, Newmarket Biomedical Ltd, NuGenerex Diagnostics, Ortho Clinical Diagnostics, Shenzhen New Industries Biomedical Engineering Co., Ltd., and Siemens Healthineers AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Syphilis Immunoassay Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Syphilis Immunoassay Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Syphilis Immunoassay Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Syphilis Immunoassay Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Syphilis Immunoassay Diagnostic Market?
6. What is the market share of the leading vendors in the Global Syphilis Immunoassay Diagnostic Market?
7. What modes and strategic moves are considered suitable for entering the Global Syphilis Immunoassay Diagnostic Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter Inc
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Technology Outlook
3.5. End User Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of the global syphilis infection caused due to unprotected sex
5.1.1.2. Government reforms targeted towards the betterment of healthcare infrastructure
5.1.1.3. Chances of mother-to-child gestational syphilis
5.1.2. Restraints
5.1.2.1. In some stages, the disease may be asymptomatic, and problems in diagnosing very early syphilis
5.1.3. Opportunities
5.1.3.1. Rising rate of abortions, stillbirth, and other abnormalities during pregnancy
5.1.3.2. Availability of rapid, automated treponemal tests and on-the-spot testing solutions
5.1.4. Challenges
5.1.4.1. Lack of awareness of syphilis immunoassay disease
5.1.4.2. The lack of skilled professionals
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Syphilis Immunoassay Diagnostic Market, by Product
6.1. Introduction
6.2. Analyzer
6.3. Kit & Reagent

7. Syphilis Immunoassay Diagnostic Market, by Technology
7.1. Introduction
7.2. CLIA
7.3. ELISA

8. Syphilis Immunoassay Diagnostic Market, by End User
8.1. Introduction
8.2. Blood Bank
8.3. Diagnostic Lab
8.4. Hospital

9. Americas Syphilis Immunoassay Diagnostic Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Syphilis Immunoassay Diagnostic Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Syphilis Immunoassay Diagnostic Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Beckman Coulter Inc
13.3. Becton, Dickinson and Company
13.4. Bio-Rad Laboratories, Inc.
13.5. bioMérieux SA
13.6. Danaher Corporation
13.7. DiaSorin S.p.A.
13.8. F. Hoffmann-La Roche Ltd
13.9. Fujirebio, Inc.
13.10. Gold Standard Diagnostics
13.11. Newmarket Biomedical Ltd
13.12. NuGenerex Diagnostics
13.13. Ortho Clinical Diagnostics
13.14. Shenzhen New Industries Biomedical Engineering Co., Ltd.
13.15. Siemens Healthineers AG

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 4. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2026
FIGURE 12. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ANALYZER, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ANALYZER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KIT & REAGENT, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KIT & REAGENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 17. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 19. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLIA, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLIA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ELISA, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ELISA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 24. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2026
FIGURE 26. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANK, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANK, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LAB, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LAB, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. ARGENTINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. INDONESIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. MALAYSIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. PHILIPPINES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. SINGAPORE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. THAILAND SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. NETHERLANDS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. QATAR SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. RUSSIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. UNITED KINGDOM SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ANALYZER, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY KIT & REAGENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY CLIA, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY ELISA, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LAB, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. AMERICAS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 15. ARGENTINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. BRAZIL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. CANADA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. MEXICO SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. ASIA-PACIFIC SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. AUSTRALIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. CHINA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. INDIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. INDONESIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. JAPAN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. MALAYSIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. PHILIPPINES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. SINGAPORE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. SOUTH KOREA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. THAILAND SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. FRANCE SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. GERMANY SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. ITALY SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. NETHERLANDS SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. QATAR SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. RUSSIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SAUDI ARABIA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH AFRICA SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. SPAIN SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. UNITED ARAB EMIRATES SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. UNITED KINGDOM SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: SCORES
TABLE 44. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: BUSINESS STRATEGY
TABLE 45. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: PRODUCT SATISFACTION
TABLE 46. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: RANKING
TABLE 47. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 48. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: MERGER & ACQUISITION
TABLE 49. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 50. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 51. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: INVESTMENT & FUNDING
TABLE 52. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 53. GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Fujirebio, Inc.
  • Gold Standard Diagnostics
  • Newmarket Biomedical Ltd
  • NuGenerex Diagnostics
  • Ortho Clinical Diagnostics
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll